158.83
                                            Schlusskurs vom Vortag:
              $157.31
            Offen:
              $156.79
            24-Stunden-Volumen:
                275.52K
            Relative Volume:
              0.15
            Marktkapitalisierung:
                $9.09B
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              -
            KGV:
              -
            EPS:
                -
            Netto-Cashflow:
                -
            1W Leistung:
              +2.26%
            1M Leistung:
              +9.91%
            6M Leistung:
                +25.35%
            1J Leistung:
              +13.10%
            Ishares Biotechnology Etf Stock (IBB) Company Profile
Firmenname
                  
                      Ishares Biotechnology Etf
                    
                Sektor
                  Branche
                  Telefon
                  
                      -
                    
                Adresse
                  
                      -
                    
                Vergleichen Sie IBB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
|   
                          
                                IBB
                            
                             Ishares Biotechnology Etf | 158.78 | 9.09B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VTI
                            
                             Vanguard Total Stock Market Etf | 335.67 | 417.53B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                SPY
                            
                             Spdr S P 500 Etf Trust | 682.95 | 372.57B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                IVV
                            
                             Ishares Core S P 500 Etf | 686.29 | 253.41B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VB
                            
                             Vanguard Small Cap Etf | 254.47 | 160.59B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                QQQ
                            
                             Invesco Qqq Trust Series 1 | 631.71 | 124.43B | 0 | 0 | 0 | 0.00 | 
Ishares Biotechnology Etf Aktie (IBB) Neueste Nachrichten
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
Analyst Explains Why He’s Investing in This Top Biotech ETF - Insider Monkey
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - Genetic Engineering and Biotechnology News
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
IBB: Biotech's Leading Players, All In One ETF (NASDAQ:IBB) - Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Biotech ETFs Bounce Back in 2025: Here's Why - TradingView
ISHARES TRUST (^IBB) stock price, news, quote and history - Yahoo
Should You Invest in the iShares Biotechnology ETF (IBB)? - MSN
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Benzinga
iShares TrustiShares Biotechnology ETF (IBB.SN) latest stock news and headlines - Yahoo
Enpro Moves To Boost Profits With $280 Million Acquisition Push - Benzinga
VanEck Biotech ETF (BBH): How to Buy - The Motley Fool
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging - The Motley Fool
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
iShares Biotechnology ETF (NQ: - FinancialContent
The Best Biotech ETFs to Buy - Kiplinger
How to Invest in the Entire Biotechnology Industry Through One ETF? - NAI500
Best Biotech ETFs to Watch Right Now - The Motley Fool
How to Invest in iShares Biotechnology ETF (IBB) - The Motley Fool
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
Biotech Sector May Flip to Market Leader by Year-End - MarketBeat
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz - Benzinga
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005 - MSN
BBH vs. IBB: How to Position for the Next Biotech Growth Cycle - AInvest
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH (NASDAQ:IBB) - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
Finanzdaten der Ishares Biotechnology Etf-Aktie (IBB)
        Es liegen keine Finanzdaten für Ishares Biotechnology Etf (IBB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
    
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App